velaglucerase alfa

Ukraine

Drugs containing this active substance

VPRIV

The drug is intended for long-term enzyme replacement therapy in patients with type I Gaucher disease.

Form: powder for solution for infusion

Active substance	Dosage
velaglucerase alfa	400 IU

Manufacturer: Shire Pharmaceuticals Ireland Limited (responsible for batch release)/Takeda Pharmaceuticals International AG Ireland Branch (responsible for batch release)